MedTrace Logo

IV Acetaminophen as an Analgesic Adjunct

NCT02621619 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 159

Last updated 2018-11-08

Study results available
· View outcomes & findings →

Summary

To determine the efficacy of intravenous (IV) acetaminophen as an analgesic adjunct to IV hydromorphone in the treatment of acute severe pain in the elderly Emergency Department (ED) patients.

Conditions

  • Acute Pain

Interventions

DRUG

IV acetaminophen + 0.5 mg IV hydromorphone

1 gram (100 ml) IV acetaminophen in addition to 0.5 mg IV hydromorphone

DRUG

Normal saline + 0.5 mg IV hydromorphone

100 cc normal saline placebo in addition to 0.5 mg IV hydromorphone

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • Montefiore Medical Center

    lead OTHER

Principal Investigators

  • Andrew Chang, MD, MS · Albany Medical College

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-10-31
Completion
2017-10-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02621619 on ClinicalTrials.gov